September 25, 2020
Recently, we had the opportunity to interview Rick Kiessig, the co-founder of Kimer Med, a company developing a broad-spectrum antiviral that has the potential to destroy a wide range of viruses. Its drug, known as VTose, is a variant of an older antiviral drug known as DRACO, which unfortunately failed to gain sufficient funding a...
